Scientific Advisory Board
Kaj Blennow, MD, PhD
Sahlgrenska University Hospital, Gothenburg, Sweden
Professor of Clinical Neurochemistry, University of Gothenburg, Sweden
Head of Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden
- Former researcher at the Medical Research Council (MRC), Sweden
Keith Crutcher, PhD
University of Cincinnati, Cincinnati, Ohio
Volunteer Professor, Department of Neurosurgery, University of Cincinnati, Cincinnati, Ohio
- Past Professor and Director of Research, Department of Neurosurgery, University of Cincinnati
- Former Scientific Review Officer, Emerging Technologies & Training in Neuroscience, Center for Scientific Review, NIH
Murali Doraiswamy, MBBS, FRCP
Duke University School of Medicine, Durham, North Carolina
Professor of Psychiatry and Medicine (Geriatrics), Duke University School of Medicine, Durham, North Carolina
Director of the Neurocognitive Disorders, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina
- Member, Duke Institute for Brain Sciences
- Member, Duke Center for Applied Genomics and Precision Medicine
- Co-author, “The Alzheimer’s Action Plan”
Serge Gauthier, MD, FRCPC
Alzheimer’s Disease Research Unit at McGill University, Montreal, Canada
Director of the Alzheimer’s Disease Research Unit at McGill University, Montreal, Canada
Professor of Neurology & Neurosurgery, Psychiatry and Medicine at McGill University, Montreal, Canada
- Member, Douglas Mental Health University Institute’s Research Center
- Membre Associé, Institut Universitaire de Gériatrie, Université de Montréal
Jakub Hort, MD, PhD, FEAN
University Hospital Motol, Prague, Czech Republic
Head of Memory Disorders Unit, University Hospital Motol, Prague, Czech Republic
Professor of Neurology, Charles University, Prague, Czech Republic
- PI Czech Brain Aging Study
- Chairman Czech Alzheimer Foundation
- Co-founder Alzheimerchain/Terrapino mobile app
Cyril Höschl, MD, DSc, FRCPsych
Charles University, Prague, Czech Republic
Professor and Chairman Emeritus, Department of Psychiatry and Clinical Psychology, the Third Faculty of Medicine, Charles University, Prague
- Founding manager and Director Emeritus of the National Institute of Mental Health, Klecany, Czech Republic
Steven Jacobsen, PhD
Creacion Ventures, Boston, MA
Creacion Ventures, Boston, MA (former WuXi Healthcare Ventures)
Adjunct Associate Professor, New York University School of Medicine, New York, New York
- Past Chief Executive Officer, American Life Science Pharmaceuticals, La Jolla, California
- Past Associate Editor “Current Alzheimer’s Research”
Diane Jorkasky, MD, FACP
Director at Alzheon, Inc., Framingham, Massachusetts
- Faculty member at UCSF, Yale, Penn and Uniformed Service of Health Sciences Medical Schools
- Past Head of Development and Chief Medical Officer at Endo Pharmaceuticals
- Past Vice President, Global Clinical Research Operations at Pfizer
Ara S. Khachaturian, PhD
Khachaturian and Associates, Potomac, Maryland
Principal, Khachaturian and Associates, Potomac, Maryland
Executive Editor of “Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association”
- Executive Vice-President, Campaign to Prevent Alzheimer’s Disease (PAD2020), Rockville, Maryland
- Chair and President of the National Biomedical Research Ethics Council (NBREC), Las Vegas, Nevada
Louis Kirby, MD
ZettaScience, Inc., Scottsdale, Arizona
Co-Founder, ZettaScience, Inc., Scottsdale, Arizona
Consulting Medical Director, Amarantus Bioscience Holdings, Phoenix, Arizona
- Founder of Pivotal Research Center in Phoenix, one of the largest medical research centers in the U.S.
- Principal investigator on nearly 400 clinical trials
Miia Kivipelto, MD, PhD
Karolinska University Hospital, Stockholm, Sweden
Director of Research and Education at the Geriatric Clinic and Head of the Unit of Clinical Trials, Karolinska Hospital, Stockholm, Sweden
Professor and Senior Geriatrician, Karolinska University Hospital, Stockholm, Sweden
- Leading expert on Alzheimer’s risk factors, early diagnoses and disease prevention
- Expert/member of advisory boards for industry related to dementia studies
- Founding member of the European Dementia Prevention Initiative (EDPI)
- Principal investigator – Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Dementia (FINGER)
William Mobley, MD, PhD
University of California, San Diego, California
Professor and Chair, Department of Neurosciences, University of California, San Diego, California
Executive Director of Down Syndrome Center for Research and Treatment at University of California, San Diego, California
- Founding Director of the Neuroscience Institute at Stanford University
- Fellow of the Royal College of Physicians
- Fellow of the American Association for the Advancement of Science
Anton Porsteinsson, MD
University of Rochester School of Medicine, Rochester, New York
Director of Memory Disorders Clinic, University of Rochester, Rochester, New York
Professor of Psychiatry, University of Rochester School of Medicine, Rochester, New York
- Director of Alzheimer’s Disease Care, Research and Education Program at the University of Rochester
Eric Reiman, MD
Banner Alzheimer’s Institute, Phoenix, Arizona
Chief Executive Officer of Banner Research and Executive Director of Banner Alzheimer’s Institute, Phoenix, Arizona
Professor of Psychiatry, University of Arizona, Tucson, Arizona
- Director of Arizona Alzheimer’s Consortium
- Clinical Director, Neurogenomics Division at the Translational Genomics Research Institute
Marwan N. Sabbagh, MD, FAAN
Phoenix, Arizona
Professor of Neurology, Phoenix, AZ
Research Professor, University of Arizona College of Medicine, Phoenix, AZ
Clinical Professor of Neurology, Creighton University, Phoenix, AZ
- Past Clinical Professor in Department of Neuroscience, UNLV
- Past Director of Cleveland Clinic Lou Ruvo Center for Brain Health
- Editor-in-chief of the Neurology and Therapy journal
Carl Sadowsky, MD
Palm Beach Neurology, West Palm Beach, Florida
Medical Director of Premiere Research Institute, Palm Beach Neurology, West Palm Beach, Florida
Clinical Professor of Neurology, Nova Southeastern University, Fort Lauderdale, Florida
- Past Director of St. Mary’s Hospital Memory Disorders Center
John Sampalis, PhD
McGill University, Montreal, Canada
CEO & Chief Scientific Officer, JSS Medical Research, Montreal, Canada
Professor of Surgery and Medicine, McGill University, Montreal, Canada
Director of Surgical Research, Jewish General Hospital, Montreal, Canada
- Reviewer for over five leading peer reviewed journals
Katerina Sheardova, MD, PhD
International Clinical Research Center (ICRC) at St. Anne's University Hospital, Brno, Czech Republic
Head of ICRC Memory Center, Brno, Czech Republic
- National delegate on Dementia and Cognitive Disorders panel of European Academy of Neurology
- Co-founder of Czech Brain Aging Study – national longitudinal study on aging
- Member of Management Board of Section on Cognitive Neurology, Czech Neurological Society
Pete Snyder, PhD
The University of Rhode Island, Kingston, Rhode Island
Professor of Biomedical and Pharmaceutical Sciences, The University of Rhode Island, Kingston, RI
- Past Professor of Neurology, The Alpert Medical School of Brown University
- Past Director and Early Clinical Leader of novel compounds for Alzheimer’s disease and schizophrenia at Pfizer
- Senior Associate Editor “Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association”
Bruno Vellas, MD, PhD
University Hospital Center, Toulouse, France
Chief, Alzheimer’s Disease Clinical and Research Center, University Hospital Center, Toulouse, France
Chairman of the Department of Internal and Geriatric Medicine, University Hospital Center, Toulouse, France
- President of the International Association of Gerontology and Aging
- Chairman of the International Academy on Nutrition and Aging
- Editor-in-chief “The Journal of Nutrition, Health and Aging”
Michael W. Weiner, MD
San Francisco, California
Professor of Radiology and Biomedical Imaging, Medicine, Psychiatry, and Neurology, Emeritus, University of California, San Francisco, California
Principal investigator of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the largest observational study of Alzheimer’s disease